XT
LFCR icon

XTX Topco’s Lifecore Biomedical LFCR Stock Holding History

XTX Topco’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.7K Buy
15,173
+221
+1% +$1.11K ﹤0.01% 3597
2026
Q1 		$55.6K Buy
+14,952
New +$103K ﹤0.01% 3287
2025
Q3 		– Sell
-20,089
Closed -$163K – 2938
2025
Q2 		$163K Sell
20,089
-510
-2% -$3.44K 0.01% 1767
2025
Q1 		$145K Buy
+20,599
New +$128K 0.01% 1773
2024
Q2 		– Sell
-12,610
Closed -$67K – 2189
2024
Q1 		$67K Buy
+12,610
New +$90.2K 0.01% 1423

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

XTX Topco's LFCR Position: Q2 2026 in Review

XTX Topco increased its Lifecore Biomedical (LFCR) stake by 1.5% in Q2 2026, buying an estimated $1.11K and bringing the position to 15,173 shares worth $79.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3597.

XTX Topco first reported a position in LFCR in Q1 2024 and has held it in 5 quarters since. The position peaked at $163K in Q2 2025. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • XTX Topco held 15,173 shares of Lifecore Biomedical worth $79.7K as of Q2 2026.
  • XTX Topco bought 221 Lifecore Biomedical shares in Q2 2026, an estimated $1.11K.
  • Lifecore Biomedical made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3597 holding.
  • XTX Topco first reported a position in Lifecore Biomedical in Q1 2024 and has held it in 5 quarters since.
  • XTX Topco's Lifecore Biomedical position peaked at $163K in Q2 2025.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.